Caio Cesar Justino

1PUBLICATIONS
7CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Dec 18, 2024
Outpatient subcutaneous alemtuzumab is feasible and safe for aplastic anemia and is associated with high response rates.

Ana Rita da Fonseca, Caio Cesar Justino, Vinicius Campos de Molla

Pageof 1

Frequent Collaborators

1 joint publications

Ana Rita da Fonseca

1 joint publications

Vinicius Campos de Molla

1 joint publications

Patricia Eiko Yamakawa

1 joint publications

Elvira Velloso